Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Ernexa Therapeutics Inc. (ERNA) had Current Ratio of 2.89 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-5.51M |
|
-- |
|
-- |
|
$5.59M |
|
$-5.59M |
|
$0.04M |
|
$-5.55M |
|
$-5.55M |
|
$-5.51M |
|
$-5.51M |
|
$-5.51M |
|
$-5.51M |
|
$-5.59M |
|
$-3.46M |
|
0.79M |
|
0.79M |
|
$-6.95 |
|
$-6.95 |
|
| Balance Sheet Financials | |
$10.00M |
|
$0.09M |
|
$0.55M |
|
$10.54M |
|
$3.46M |
|
-- |
|
$0.23M |
|
$3.68M |
|
$6.86M |
|
$6.86M |
|
$6.86M |
|
1.17M |
|
| Cash Flow Statement Financials | |
$-2.26M |
|
$-0.00M |
|
$9.56M |
|
$1.88M |
|
$9.18M |
|
$7.29M |
|
$0.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
2.89 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-80.29% |
|
-80.27% |
|
-52.22% |
|
-80.27% |
|
$5.88 |
|
$-2.86 |
|
$-2.86 |
|